IMPACT OF A PHARMACIST MEDICATION ADHERENCE CONSULTATION PROGRAM ON HEALTH CARE COSTS AND RISK OF HOSPITALIZATION
Author(s)
Wade RL1, Hill JW1, Akinbosoye O2, Jiang Z2, Mu Y2, Sun K1, Karkare S3, Taitel MS2
1IMS Health, Plymouth Meeting, PA, USA, 2Walgreen Co., Deerfield, IL, USA, 3IMS Health, Deerfield, IL, USA
OBJECTIVES: Non-adherence is associated with poorer health outcomes and increased costs. This study evaluated the impact of a community pharmacist medication adherence consultation on health care costs and the risk of hospitalization. METHODS: Patients initiating therapy within 16 drug classes were offered face-to-face or telephonic consultations by a Walgreens pharmacist between 2/7/2013 – 10/6/2013. Consultation included motivational interviewing focused on fitting medication-taking behavior into patients’ daily routine, and removing barriers to adherence. Patients were assigned to two groups according to the intensity of consultation: no consultations (NC) and ≥ 1 consultations received (CR). Patients were linked deterministically to the IMS Health PharMetrics Plus database such that 6 months of pharmacy and medical claims data pre and post their index date could be analyzed. Cost differences from the pre to post-index periods were compared between NC and CR groups, using difference in differences estimation in a GLM model, controlling for demographic and clinical confounders. RESULTS: CR patients (n=58,449) and NC patients (n=53,870) had similar age (48.2 vs. 47.7 years), gender (59.0% vs. 57.7% female) and disease burden (0.61 vs. 0.58 for Charlson Comorbidity Index, CCI). CR patients incurred significantly lower pre- to post-index GLM-adjusted total health care costs (-$266/-4.3% lower, p=0.001), comprised of lower inpatient (-$231, p=0.009), lower pharmacy (-$43, p<0.0001), and similar outpatient costs (-$36, p=0.279); and had a lower probability of hospitalization (OR: 0.92, 95% CI: 0.86, 0.98, p=0.009). CR patients with a CCI equal to 1-2 realized the greatest cost savings (-$688, p=0.001) compared to patients with CCI=0 (-$106, p=0.051), and CCI≥3 ($575, p=0.293). CONCLUSIONS: Patients receiving structured pharmacist consultations focused on improving medication adherence were shown to have significantly lower health care costs and risk of hospitalization. Ongoing studies will explore underlying relationships between program participation, adherence, and impact on health outcomes and costs.
Conference/Value in Health Info
2015-05, ISPOR 2015, Philadelphia, PA, USA
Value in Health, Vol. 18, No. 3 (May 2015)
Code
MA1
Topic
Economic Evaluation
Topic Subcategory
Cost-comparison, Effectiveness, Utility, Benefit Analysis
Disease
Multiple Diseases